By Top Class Actions  |  January 30, 2025

Category: Legal News
Product photo of recalled injection medication, representing the phenylephrine hydrochloride injection recall.
(Photo Credit: U.S. Food & Drug Administration)

Phenylephrine hydrochloride injection recall overview: 

  • Who: Provepharm issued a recall for one lot of its phenylephrine hydrochloride injection.
  • Why: The recall was initiated over concerns the drug may be contaminated with foreign material.
  • Where: The recall was issued to the hospital/institutional level. 

Provepharm Inc. issued a recall for one lot of its phenylephrine hydrochloride injection over concerns it may be contaminated with foreign material. 

The recall involves phenylephrine hydrochloride Injection USP 10 mg/mL with an expiration date of December 2025 and lot number 24020027. 

Provepharm said it initiated the recall after a pharmacy informed the company that it observed a “visible black particulate matter” found in a single-sealed vial of the phenylephrine hydrochloride injection drug. 

“Administration of an injectable product containing particulate matter may cause local irritation or swelling as a response to the foreign material,” the recall says. 

Phenylephrine hydrochloride injection treats ‘clinically important’ hypotension 

The recalled drug is used to treat “clinically important” hypotension primarily occurring due to vasodilation in the setting of anesthesia, according to the recall. 

The phenylephrine hydrochloride injection recall is to the hospital/institutional level. Distributors, wholesalers, compounding companies and hospitals are advised to immediately stop using the drug and to return it to Provepharm’s recall provider, Sedgwick. 

Consumers are advised to contact their physician or healthcare provider if they experience any problems that may be related to the recalled phenylephrine hydrochloride injection drug.

In October 2023, Exela issued a recall for several lots of sodium bicarbonate injection under the Exela and Civica brands and cysteine hydrochloride injections under the Midazolam and ELCYS brands after silicone particulate matter was found in the drugs during a routine inspection. 

Are you affected by the phenylephrine hydrochloride injection recall? Let us know in the comments.


Don’t Miss Out!

Check out our list of Class Action Lawsuits and Class Action Settlements you may qualify to join!


Read About More Class Action Lawsuits & Class Action Settlements:

We tell you about cash you can claim EVERY WEEK! Sign up for our free newsletter.

5 thoughts onRecall initiated for phenylephrine hydrochloride injection due to potential foreign material

  1. Joseph Clark says:

    Add me

  2. Phill says:

    Please add me

  3. RUPAL SHAH says:

    Add me

  4. PRAKASH C SHAH says:

    Add me

  5. renee konias says:

    add me

Leave a Reply

Your email address will not be published. By submitting your comment and contact information, you agree to receive marketing emails from Top Class Actions regarding this and/or similar lawsuits or settlements, and/or to be contacted by an attorney or law firm to discuss the details of your potential case at no charge to you if you qualify. Required fields are marked *

Please note: Top Class Actions is not a settlement administrator or law firm. Top Class Actions is a legal news source that reports on class action lawsuits, class action settlements, drug injury lawsuits and product liability lawsuits. Top Class Actions does not process claims and we cannot advise you on the status of any class action settlement claim. You must contact the settlement administrator or your attorney for any updates regarding your claim status, claim form or questions about when payments are expected to be mailed out.